Evidence supporting the use of: Enterococcus (various species)
For the health condition: Inflammatory Bowel Disorders
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Enterococcus species, particularly Enterococcus faecium and Enterococcus faecalis, have been investigated as part of probiotic formulations intended to support or treat Inflammatory Bowel Disorders (IBD), such as Crohn’s disease and ulcerative colitis. Scientific interest stems from their role as lactic acid bacteria with potential to modulate the gut microbiota, enhance epithelial barrier function, and influence immune responses. Some commercial probiotics (e.g., formulations like Symbioflor and Mutaflor, though the latter contains Escherichia coli Nissle 1917, not Enterococcus) include Enterococcus strains, and small clinical studies and case reports suggest possible benefits in reducing disease activity or maintaining remission in IBD. However, the quality and scale of evidence are limited: most available studies are small, heterogeneous in design, and often include Enterococcus species as part of multi-strain preparations, making it hard to attribute effects to Enterococcus alone. Meta-analyses generally find insufficient evidence to recommend Enterococcus probiotics as standard therapy for IBD, and safety concerns exist due to opportunistic infections associated with some Enterococcus strains, particularly in immunocompromised individuals. Therefore, while there is some scientific investigation, the evidence is modest (rated 2/5), and Enterococcus is not considered a first-line probiotic for IBD at this time. Continued research is needed to clarify efficacy and safety.
More about Enterococcus (various species)
More about Inflammatory Bowel Disorders
Other ingredients used for Inflammatory Bowel Disorders
2'-Fucosyllactoseakkermansia muciniphila
algal oil
aloe vera
alpha-glycosyl isoquercitrin
alpha-linolenic acid (ALA)
anthocyanins
bacillus clausii
bacillus subtilis
barberry
barley
beta caryophyllene
bifidobacterium bifidum
bifidobacterium breve
bifidobacterium infantis
bifidobacterium lactis
bifidobacterium longum
butyrate triglyceride
cat's claw
chamomile
citrus pectin
Coptis chinensis
turmeric
curcumin
dandelion
DHA (docosahexaeonic acid)
EPA (eicosapentaenoic acid)
fish oil
flaxseed
fructooligosaccharides (FOS)
inulin
isomalto-oligosaccharide
l-glutamine
lactobacillus brevis
lactobacillus casei
lactobacillus crispatus
lactobacillus fermentum
lactobacillus gasseri
lactobacillus lactis
lactobacillus paracasei
lactiplantibacillus plantarum
lactobacillus reuteri
lactobacillus rhamnosus
lactobacillus salivarius
lactococcus lactis
licorice root
luteolin
marshmallow
n-acetyl-glucosamine
n-acetyl-cysteine (NAC)
nicotinamide riboside
omega-3 fatty acids
pectin
peppermint oil
butyric acid
psyllium
reishi mushroom
saccharomyces boulardii
shiitake mushroom
slippery elm bark
specialized pro-resolving mediators (SPMs)
spirulina
streptococcus thermophilus
tributyrin
Urolithin A
vitamin C
vitamin D
vitamin D3
xylanase
xylooligosaccharides
zinc
bentonite
punarnava
rubia cordifolia
swertia
myrrh
algae
7,14-Hydroxy-Docosapentaenoic Acid
Apigenin
Andrographolide
Avocado
anthocyanidins
Acemannan
Arabinoxylan
Apocynin
Arctiin
Astragalin
Bifidobacterium
Bifidobacterium adolescentis
Brassica
Boswellic Acid
Butternut
Basidiomycota
Boswellia
Bacillus licheniformis
Bioflavonoids
Bifidobacterium animalis
Bacteria
Bifidobacteria
Bacillus
Cichoric acid
Cruciferous
Casticin
Celandine
Chirata
Cannabidiol
Enterococcus
Eicosapentaenoic Acid
Ellagitannin
Fiber
Flavans
Other health conditions supported by Enterococcus (various species)
Antibiotics (alternatives to)Antibiotics (side effects of)
Cholesterol (high)
Constipation (adults)
Diarrhea
Inflammatory Bowel Disorders
Irritable Bowel Syndrome